RT Journal Article
SR Electronic
A1 Parry, Nicola
T1 Lurasidone Effective in Major Depressive Disorder With Mixed Features
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 11
SP 11
OP 11
DO 10.1177/1559897715593715
UL http://mdc.sagepub.com/content/15/11/11.abstract
AB The first-ever placebo-controlled trial in major depressive disorder with mixed features demonstrated that lurasidone, an atypical antipsychotic agent, was efficacious in reducing depressive symptoms in these patients and was also well tolerated when compared with placebo.